- Home
- NRIX vs NOG Comparison
NRIX vs NOG Comparison
Compare NRIX & NOG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NRIX | NOG |
|---|---|---|
| Founded | 2009 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.5B | 2.1B |
| IPO Year | 2020 | 2000 |
Fundamental Metrics
Financial Performance| Metric | NRIX | NOG |
|---|---|---|
| Price | $23.17 | $20.87 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 12 | 8 |
| Target Price | $30.50 | ★ $31.14 |
| AVG Volume (30 Days) | 1.9M | ★ 3.9M |
| Earning Date | 04-08-2026 | 04-28-2026 |
| Dividend Yield | N/A | ★ 6.44% |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $76,987,000.00 | ★ $2,475,723,000.00 |
| Revenue This Year | N/A | $14.07 |
| Revenue Next Year | $48.05 | $4.24 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 99.31 | 11.23 |
| 52 Week Low | $8.20 | $17.18 |
| 52 Week High | $25.09 | $31.17 |
Technical Indicators
Market Signals| Indicator | NRIX | NOG |
|---|---|---|
| Relative Strength Index (RSI) | 61.64 | 56.99 |
| Support Level | $14.63 | $20.74 |
| Resistance Level | $24.98 | $22.86 |
| Average True Range (ATR) | 1.25 | 0.73 |
| MACD | -0.23 | 0.45 |
| Stochastic Oscillator | 50.58 | 94.74 |
Price Performance
Historical ComparisonAbout NRIX Nurix Therapeutics Inc.
Nurix Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and potential commercialization of targeted protein degradation therapies for cancer and inflammatory diseases. It utilizes an integrated discovery platform that incorporates artificial intelligence and ligase expertise to support its research activities. The company's pipeline includes Bexobrutideg (NX-5948), Zelebrudomide (NX-2127), NX-1607 and BRAF degrader. These drug candidates target specific proteins involved in immune and cancer-related pathways. It operates in a single business segment.
About NOG Northern Oil and Gas Inc.
Northern Oil & Gas Inc is an independent energy company engaged in the acquisition, exploration, development, and production of crude oil and natural gas properties. Its principal business is crude oil and natural gas exploration, development, and production. The company's oil and natural gas sales come from three geographic areas in the United States: the Williston Basin (North Dakota and Montana), the Permian Basin (New Mexico and Texas), the Uinta Basin, and the Appalachian Basin (Pennsylvania and Ohio).